Ventyx Biosciences Inc.
VTYX | NASDAQ
$14
$0 (0.00%)
Mar 6, 2026, 9:30 AM ET · Market open
Fiscal Quarter Period Ending | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 | Q4 2020 Dec 30, 2020 | Q3 2020 Sep 29, 2020 | Q2 2020 Jun 29, 2020 | Q1 2020 Mar 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -22.83M | -26.99M | -27.44M | -29.35M | -35.25M | -31.95M | -38.57M | -46.75M | -54.03M | -53.25M | -38.93M | -35.21M | -30.46M | -20.02M | -22.73M | -17.77M | -12.77M | -15.56M | -37.65M | -16.7M | -7.16M | -2.16M | -2.16M |
Depreciation & Amortization | 326K | 323K | 356K | 315K | 309K | 316K | 408K | 403K | 265K | 139K | 134K | 150K | 127K | 103K | 90K | 16K | 9K | 4K | 1K | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 4.6M | 4.58M | 5.03M | 5.17M | 5.45M | 5.77M | 6.54M | 6.15M | 8.01M | 7.87M | 6.57M | 4.83M | 4.17M | 4.13M | 3.44M | 1.39M | 969K | 288K | 80K | 14K | 14K | 8.5K | 8.5K |
Other Working Capital | 1.36M | 3.55M | -1.26M | 1.87M | 935K | 2.05M | -12.78M | -5.68M | 8.02M | 733K | 3.48M | -7.03M | -6.14M | -1.85M | 8.25M | 1.37M | -1.12M | 967K | 364K | -120K | -167K | 254K | 254K |
Other Non-Cash Items | -1.06M | -1.31M | -1.59M | -2.08M | -2.61M | -2.75M | -2.03M | 8.34M | -2.14M | -2.49M | -2.08M | -1.73M | -386K | -109K | n/a | -98K | n/a | 15.38M | 34.08M | 15.26M | 4.92M | 683K | 683K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10.54M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.06M | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.46M | 2.13M | -2.07M | 2.7M | -3.36M | 4.07M | -13.97M | -9.26M | 13.23M | -1.55M | 3.39M | -15.3M | 2.57M | 1.1M | 6.47M | 1.76M | 755K | 1.04M | 467K | -461K | 341K | 254K | 254K |
Operating Cash Flow | -17.51M | -21.28M | -25.72M | -23.25M | -35.46M | -24.54M | -47.63M | -51.66M | -34.66M | -49.28M | -30.92M | -47.26M | -23.99M | -14.79M | -12.73M | -14.7M | -11.04M | -9.92M | -3.02M | -1.89M | -1.88M | -1.21M | -1.21M |
Capital Expenditures | -50K | -42K | -16K | -6K | n/a | -60K | -175K | -211K | -48K | -195K | -60K | -112K | -97K | -28K | -38K | -48K | -203K | -11K | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -46.34K | -38.94K | n/a | n/a | n/a | -64.26K | n/a | n/a | n/a | n/a | n/a | 1.9M | n/a | n/a | n/a | n/a |
Purchase of Investments | -34.77M | -33.87M | -19.48M | -75.24M | -32.25M | -150.71M | -25.45M | -28.66M | -70.79M | -63.99M | -108.84M | -204.73M | -17.11M | -56.72M | -68.68M | -159.54M | -72.96M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 51.88M | 59.1M | 45.91M | 64.25M | 61.5M | 75.25M | 67.39M | 75M | 109.73M | 99M | 90M | 64M | 81.37M | 75M | 52.21M | 16.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 46.34K | 38.94K | n/a | n/a | n/a | 64.26K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 17.05M | 25.19M | 26.42M | -11M | 29.25M | -75.52M | 41.77M | 46.13M | 38.89M | 34.82M | -18.9M | -140.84M | 64.16M | 18.25M | -16.5M | -143.09M | -73.16M | -11K | 1.9M | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 450K | 2.08M | 1.9M | n/a | n/a |
Common Stock Repurchased | n/a | 68K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 203K | n/a | n/a | 222K | n/a | 140K | 92K | n/a | n/a | 2.52M | 191K | 777K | 1.26M | 115K | n/a | n/a | -427K | -275K | n/a | 2K | n/a | 1.08M | 1.08M |
Financial Cash Flow | 203K | 68K | n/a | -25K | 26.86M | -906K | 96.18M | 585K | 1.63M | 2.47M | 48.65M | -10.36M | 177.79M | 249K | 86K | 159.58M | 50.38M | 56.73M | 56.87M | 2.08M | 1.9M | 1.08M | 1.08M |
Net Cash Flow | -331K | 4.23M | 816K | -34.51M | 20.84M | -100.97M | 90.32M | -5.03M | 5.87M | -11.95M | -1.15M | -198.45M | 217.93M | 3.65M | -29.1M | 1.81M | -33.8M | 46.8M | 55.75M | 192K | 18K | -137.5K | -137.5K |
Free Cash Flow | -17.56M | -21.32M | -25.73M | -23.26M | -35.46M | -24.6M | -47.8M | -51.87M | -34.71M | -49.48M | -30.98M | -47.38M | -24.09M | -14.82M | -12.76M | -14.75M | -11.24M | -9.93M | -3.02M | -1.89M | -1.88M | -1.21M | -1.21M |
Adj. Free Cash Flow | -22.16M | -25.89M | -30.77M | -28.42M | -40.91M | -30.37M | -54.34M | -58.01M | -42.72M | -57.35M | -37.55M | -52.2M | -28.25M | -18.95M | -16.21M | -16.14M | -12.21M | -10.21M | -3.1M | -1.9M | -1.9M | -1.22M | -1.22M |
Maintenance CapEx | -50K | -42K | -16K | -6K | n/a | -60K | -175K | -211K | -48K | -139K | -60K | -112K | -97K | -28K | -38K | -16K | -9K | -4K | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -56K | n/a | n/a | n/a | n/a | n/a | -32K | -194K | -7K | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -17.56M | -21.32M | -25.73M | -23.26M | -35.46M | -24.6M | -47.8M | -51.87M | -34.71M | -49.42M | -30.98M | -47.38M | -24.09M | -14.82M | -12.76M | -14.71M | -11.05M | -9.92M | -3.02M | -1.89M | -1.88M | -1.21M | -1.21M |
Add to Watchlist
Select watchlists to add or remove VTYX